What are the risks of low testosterone?

Pro Research Analysisby

Searched over 200M research papers

Analyzed relevant papers

Consensus Meter

Yes

Possibly

Risks of Low Testosterone: A Comprehensive Overview

Increased Mortality Risk

All-Cause Mortality

Low testosterone levels are significantly associated with an increased risk of all-cause mortality. Studies have shown that men with low serum testosterone levels have a higher likelihood of dying from various causes compared to those with normal levels. For instance, a population-based study found that men with low testosterone had a 2.24 times higher risk of all-cause mortality. Another study confirmed that men with the lowest quartile of testosterone levels were 40% more likely to die than those with higher levels. This association remains significant even after adjusting for multiple risk factors such as age, lifestyle, and preexisting health conditions .

Cardiovascular Mortality

Low testosterone is also linked to an increased risk of cardiovascular mortality. Research indicates that men with low testosterone levels have a higher risk of dying from cardiovascular diseases (CVD). For example, a meta-analysis found that a 1-standard deviation decrease in total testosterone increased the risk of cardiovascular mortality by 100%. Similarly, another study reported that low testosterone levels predicted a 2.56 times higher risk of death from CVD. These findings suggest that low testosterone could serve as a predictive marker for cardiovascular mortality .

Cardiovascular Events

Increased Risk of Cardiovascular Events

Low testosterone levels are associated with a higher incidence of cardiovascular events such as myocardial infarction (MI) and stroke. A study involving men with metabolic syndrome and low HDL-cholesterol found that those with low testosterone had a 24% higher risk of composite cardiovascular outcomes, including CHD death, MI, and stroke. Another meta-analysis confirmed that low testosterone levels increased the risk of cardiovascular events by 20%. These findings highlight the potential role of testosterone in cardiovascular health .

Cancer Risk

Prostate Cancer

Interestingly, low testosterone levels may have a complex relationship with prostate cancer risk. A collaborative analysis of 20 prospective studies found that men with low free testosterone concentrations had a lower risk of overall prostate cancer but a nonsignificantly higher risk of high-grade disease. This suggests that while low testosterone might reduce the risk of developing prostate cancer, it could potentially be associated with more aggressive forms of the disease.

Metabolic and Chronic Diseases

Type 2 Diabetes and Metabolic Syndrome

Low testosterone levels are a risk factor for metabolic syndrome and type 2 diabetes. Men with low testosterone are more likely to develop conditions such as visceral obesity, insulin resistance, and hyperglycemia. A randomized controlled trial found that testosterone treatment reduced the incidence of type 2 diabetes in men with low testosterone levels, indicating a potential therapeutic role for testosterone in managing metabolic disorders.

Chronic Kidney Disease

In men with chronic kidney disease (CKD), low testosterone levels are linked to adverse clinical outcomes. A meta-analysis revealed that a decrease in testosterone levels independently increased the risk of all-cause mortality, cardiovascular events, and infectious events among male CKD patients. This underscores the importance of monitoring and potentially treating low testosterone in this population .

Conclusion

Low testosterone levels pose significant risks to men's health, including increased mortality, higher incidence of cardiovascular events, and potential complications in chronic diseases like CKD and type 2 diabetes. While low testosterone may reduce the risk of prostate cancer, it could be associated with more aggressive disease forms. These findings highlight the need for further research and potential therapeutic interventions to mitigate the risks associated with low testosterone.